Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients?

Sung Won ChungYoung ChangHyo Young LeeEun Ju ChoJeong-Hoon LeeSu Jong YuJung Hwan Yoon Yun Joon Kim

Published in: Gastroenterology research and practice (2018)

For patients with suppressed HBV DNA, the efficacy of TDF monotherapy as maintenance therapy is comparable to that of entecavir plus TDF combination therapy.

Keyphrases

combination therapy
multidrug resistant
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
hepatitis b virus
drug resistant
prognostic factors
bone marrow
escherichia coli
cell free
acinetobacter baumannii
klebsiella pneumoniae
cell therapy
liver failure